Background At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical
trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 …

Background Rotavirus gastroenteritis causes many deaths in infants in sub-Saharan Africa.
Because rotavirus vaccines have proven effective in developed countries but had not been …

Background Rotavirus vaccine has proved effective for prevention of severe rotavirus
gastroenteritis in infants in developed countries, but no efficacy studies have been done in …

Background Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality
among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized …

BackgroundThe objectives of this study were to evaluate the association between varicella-zoster
virus (VZV)–specific humoral and cell-mediated immunity (CMI) to herpes zoster (HZ) …

The nucleocapsid (HBcAg) of the hepatitis B virus (HBV) has been suggested as a carrier
moiety for vaccine purposes. We investigated the influence of the position of the inserted …

The hepatitis B virus (HBV) nucleocapsid or core antigen (HBcAg) is extremely immunogenic
during infection and after immunization. For example, during many chronic infections, …

mRNA-1273 Vaccine Efficacy against the Delta Variant Participants who had received
placebo in a previous phase of this trial were offered the mRNA-1273 vaccine in the open-label …

Initial approaches for rotavirus vaccines were based on the classical “Jennerian” approach
and utilized simian and bovine rotavirus strains, which provided cross-protection against …

A prophylactic vaccine to prevent the congenital transmission of human cytomegalovirus (HCMV)
in newborns and to reduce life-threatening disease in immunosuppressed recipients of …